Latest filing published 12 Feb 2024 for Kyverna Therapeutics, Inc., €9.2M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -91.0%Entry US$29.71 · Close at T+365 US$2.66
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Northpond Ventures III GP, LLC: trading record in brief
This profile gathers the share dealings of Northpond Ventures III GP, LLC in Kyverna Therapeutics, Inc. Altogether 2 filings, all relating to 12 February 2024.
The open-market record is one-sided, with 1 purchase worth €9.2M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 12 February 2024, reports an open-market purchase of €9.2M in Kyverna Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Northpond Ventures III GP, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 450,000 shares@ US$22.00100.0% of flowCommon StockSEC:0000950170-24-014000:1Canonical exit: 12 May 2024 (T+90)
- 2,805,426 sharesCommon StockSEC:0000950170-24-014000:0
2 of 2 declarations
